ARTICLE | Financial News
AxoGen raises $123M in upsized follow-on
May 9, 2018 6:07 PM UTC
AxoGen Inc. (NASDAQ:AXGN) raised $123 million through the sale of 3 million shares at $41 in an upsized follow-on underwritten by Jefferies, Leerink Partners, William Blair and JMP Securities. The price is a 5% discount to AxoGen’s close of $43.15 on May 7, when the company proposed after hours to sell 2 million shares.
AxoGen markets a portfolio of products for peripheral nervous system repair, including the AVANCE nerve graft, which comprises decellularized allograft nerves recovered from cadaveric donors. ...
BCIQ Company Profiles